Women are twice as likely as men to suffer from stress-related affective disorders, and as a result, are also at a greater risk of developing comorbid cardiovascular disease. This proposal investigates the estrogen (E)- mediated neural mechanisms that we suggest are initiated in the central amygdala (CeA) to promote innate stress vulnerability to both the emergence of negative valence and exaggerated cardiac sympathetic activation. The proposed series of studies relies on the use of a witness stress paradigm whereby a male or female rodent is located in a protected region of a dominant resident's cage and witnesses a social conflict between the resident and a smaller male intruder. Following stress exposure, females with either intact ovarian hormones, or ovariectomized with E replacement (OVX+E) exhibit negative valence (decreased sucrose preference, increased burying) and exaggerated cardiac sympathetic levels (elevated resting blood pressure) while OVX with vehicle replacement (OVX+V) and intact males are resilient, making this model ideal to study the role of estrogen on increased stress susceptibility.
Aim 1 expands upon preliminary data that support the hypothesis that ovarian hormones, in particular E, exacerbate stress susceptibility. These studies will identify sex differences and estrogenic effects on behavioral and sympathetic indices of stress-related pathology.
Aim 2 utilizes direct intra-CeA administration of an E receptor (ER) agonist (DPN) or antagonist (PHTPP), to activate or block, respectively, the ERs in the CeA. We hypothesize that inhibiting the ER in this brain region will enhance stress resiliency in the innate susceptible (intact-cycling) and induced susceptible (OVX+E) female groups, while activating the receptor will promote vulnerability in the induced resilient group (OVX). One known effect of E is its ability to increase the stress-related neuropeptide corticotropin-releasing factor (CRF), a peptide that is abundant in the CeA and is capable of inducing enhanced behavioral and sympathetic fear responses. Our data indicate that intact females exhibit increased CRF in the CeA, but only if they have a history of stress exposure. Therefore, Aim 2 will also identify if these ER treatments affect CRF expression in the CeA. Finally, Aim 3 will use virus-mediated gene transfer to reduce CRF levels in the CeA to determine whether the susceptibility-enhancing effects of the E are dependent upon CRF. Moreover, using in vivo microdialysis, studies in Aim 3 will identify whether increased CRF in the CeA has consequences on the major stress sensitive target the locus coeruleus (LC). CRF release and neuronal activity will be measured in the LC during stress/control and will identify if intact females exhibit increased CRF release in the LC and whether this translates to elevated activity. The ability of shRNA CRF knockdown in the CeA to affect LC activity and CRF release will also be assessed. Together, these studies will provide evidence of a targeted mechanism increasing susceptibility to affective disorders and comorbid cardiac dysfunction in females. These studies propose a novel and ?translatable? pathway by which E may regulate innate stress vulnerability in women.

Public Health Relevance

Women with active circulating ovarian hormones are twice as likely to develop depression than males. This increased susceptibility begins during puberty and ends following menopause, suggesting that ovarian hormones contribute to the increased incidence of major depression in females. The overall goal of this project is to identify how ovarian hormones interact with stress-related neurochemicals within the brain to increase susceptibility to depressive-like behaviors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH113892-02
Application #
9669139
Study Section
Neuroendocrinology, Neuroimmunology, Rhythms and Sleep Study Section (NNRS)
Program Officer
Winsky, Lois M
Project Start
2018-03-16
Project End
2022-12-31
Budget Start
2019-01-01
Budget End
2019-12-31
Support Year
2
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of South Carolina at Columbia
Department
Pharmacology
Type
Schools of Medicine
DUNS #
041387846
City
Columbia
State
SC
Country
United States
Zip Code
29208
Lindsey, Merry L; Gray, Gillian A; Wood, Susan K et al. (2018) Statistical considerations in reporting cardiovascular research. Am J Physiol Heart Circ Physiol 315:H303-H313
Finnell, Julie E; Wood, Susan K (2018) Putative Inflammatory Sensitive Mechanisms Underlying Risk or Resilience to Social Stress. Front Behav Neurosci 12:240